• Detects Aneusomy and
Polysomy of Chromosome 17
• Resolves Cases with
Discordant IHC and FISH
results
• HER2/neu and Chromosome
17 clarity
• Overall Genomic Assessment
of Tumor
• Delineate Key Genomic Gains
and Losses
• Ideal for Chronic Lymphocytic
Leukemia (CLL)
• Consistent results from
Formalin-Fixed Parrafin
Embedded (FFPE) Tissue
• Identify therapeutic targets